|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/55 | |
| A61K 31/506 | |||
| A61K 31/4545 | |||
| A61K 31/501 | |||
| A61P 43/00 | |||
| A61P 25/00 | |||
| A61P 25/26 | |||
| A61P 31/00 | |||
| A61P 31/18 |
| (11) | Patento numeris | 2945637 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14703425.0 |
| Europos patento paraiškos padavimo data | 2014-01-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/058224 |
| Data | 2014-01-13 |
| (87) | Numeris | WO 2014/111837 |
| Data | 2014-07-24 |
| (30) | Numeris | Data | Šalis |
| 201361752765 P | 2013-01-15 | US |
| (72) |
FENDT, Markus, CH
FEUERBACH, Dominik, CH
JOHNS, Donald, US
LOPEZ-LOPEZ, Cristina, CH
MCALLISTER, Kevin Hall, CH
SOVAGO, Judit, CH
WEISS, Markus, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS |
| USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS |